Reuters
Published Sep 28, 2009 07:48AM ET
* Abbot to buy Solvay's drugs unit for $6.6 billion
* Xerox will acquire ACS in a $6.4 billion deal
* For up-to-the-minute market news, click [STXNEWS/US] (Adds deal details, byline)
By Rodrigo Campos
NEW YORK, Sept 28 (Reuters) - U.S. stock index futures rose on Monday after three days of losses on Wall Street as more mergers and the last days of the third quarter encouraged investors.
Xerox Corp
Xerox shares fell 8.8 percent to $8.23 in premarket trade while ACS shot up 27 percent to $60.
Abbott Laboratories
Abbott stock edged up 1.5 percent.
"We're getting back into the routine of weekly (merger and acquisition) announcements, which is positive going forward," said Peter Cardillo, chief market economist at Avalon Partners in New York.
"Over the next couple of days we might see some window dressing. There's still a lot of money out there," Cardillo said, referring to the expected asset repositioning during the last days of the quarter.
S&P 500 futures
The Dutch biotechnology firm Crucell
Data due Monday include the Federal Reserve Bank of Chicago releases its National Activity Index for August at 8:30 a.m. (1230 GMT). The index read -0.74 in July.
China Unicom , that country's No. 2 mobile
carrier, said Apple Inc's
U.S. stocks fell for a third straight day on Friday on disappointing housing and durable goods data, while Research In Motion's Inc's lackluster results dented optimism about technology spending. (Editing by Padraic Cassidy) ((rodrigo.campos@thomsonreuters.com; + 1 646-223-6344; Reuters Messaging: rodrigo.campos.reuters.com@reuters.net))
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.